Takeda H1 EPS Surges, Revenue Up 8.4%; Upgrades FY26 Outlook
(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK), Thursday reported a 171.8 percent surge in first half earnings compared to the prior year. Looking ahead to the full year 2026, the company raised its outlook.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.